Table 4.
Summary of geometric mean, geometric mean ratio, and 90% confidence internal (90% CI) of pharmacokinetic parameters between WM and WM + CMF1.
Analyte | Parameters | Geometric mean | GM Ratio, %b | 90% CI, %c | |
---|---|---|---|---|---|
WM (n = 14) |
WM + CMF1 (n = 14) |
||||
OA | C max (ng/mL) | 62.42 | 48.81 | 78.19 | 60.82–100.51 |
AUC0–12 h (ng·h/mL) | 129.86 | 124.76 | 96.08 | 88.48–104.33 | |
12 h Cum. amt. (μg)a | 2745.53 | 2726.98 | 99.32 | 85.56–115.30 | |
| |||||
OC | C max (ng/mL) | 526.27 | 480.59 | 91.32 | 84.81–98.33 |
AUC0–12 h (ng·h/mL) | 4453.91 | 4067.40 | 91.32 | 83.80–99.52 | |
12 h Cum. amt. (μg)a | 71215.61 | 61224.10 | 85.97 | 76.64–96.44 | |
| |||||
OC/OA | AUC0–12 h ratio | 34.30 | 32.60 | 95.05 | 85.64–105.50 |
12 h Cum. amt. ratio | 25.94 | 22.45 | 86.56 | 76.49–97.94 |
a12 h cumulative amount of analyte in urine.
bGeometric mean ratio of (WM + CMF1)/WM.
c90% CI criteria of 80%–125% [10].